Through powerful and lasting partnerships, the Institute for Hepatitis
and Virus Research (IHVR) - also known as the Pennsylvania Commonwealth
Institute - seeks to find cures for viral hepatitis, nurture biotechnology
entrepreneurship, train future researchers, and provide information and
support to those affected by viral hepatitis. Partnerships enable the
IHVR to maximize its resources and achieve greater scientific impact than
it could alone.
B Foundation is a 501(c)(3) nonprofit organization dedicated
to finding a cure and improving the quality of life for those affected
by hepatitis B worldwide. In 2003, the Foundation established the Institute
for Hepatitis and Virus Research (IHVR) to serve its research needs and
to house the Hepatitis
B Foundation Lab, which is dedicated solely to hepatitis B research.
The Hepatitis B Foundation and the IHVR reside in the same facility, which
allows a sharing of valuable resources to achieve their complementary
research and outreach mission.
Institute for Biotechnology and Virology Research (Drexel
Institute) is a new research division, established in July 2004 by Drexel
University College of Medicine , which shares space and resources
with the Institute for Hepatitis and Virus Research (IHVR) and the Hepatitis
B Foundation in Bucks County, PA, to further their mutual research
goals. Drexel University College of Medicine, formerly MCP Hahnemann University,
is located in Philadelphia, PA, and is the largest private medical school
in the nation and a leader in health science education and research.
Department of Health
The Pennsylvania Department of Health is a leader in the nation because
of its significant commitment to promoting viral hepatitis awareness,
education and research in the state. For many years, the PA Department
of Health has successfully partnered with the Hepatitis B Foundation to
implement viral hepatitis outreach programs. As a result, the PA Department
of Health awarded a major grant to the Institute for Hepatitis and Virus
Research (IHVR) in 2004, and renewed the grant for fiscal year 2005, to
support its viral hepatitis research and outreach mission.
The IHVR provides sub-awards to the Hepatitis
B Foundation for its comprehensive educational programs, and to the
for complementary research programs. Every year the Secretary of Health,
Physician General, and other senior administrative leaders from the PA
Department of Health are invited to visit and to hear firsthand about
the good work being done by the IHVR and the Hepatitis B Foundation.
Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania is an independent
nonprofit economic development organization, supported by the Pennsylvania
Department of Community and Economic Development, to foster dynamic relationships
among companies, investors, research institutions and the university community.
The Institute for Hepatitis and Virus Research (IHVR) receives a grant
from Ben Franklin Technology Partners to coordinate the Regional Biotechnology
Council of Central Bucks and the Ben Franklin Innovations Center, which
assists “start-up” biotech companies in the region.
In July 2004, the Hepatitis
B Foundation entered into an agreement with the University of Oxford
to sponsor a joint training program to recruit college graduates into
science who will be mentored and supervised by scientists from the Institute
for Hepatitis and Virus Research (IHVR) and Drexel
Institute. Upon successful completion of the training program, qualified
candidates will be eligible to apply for enrollment in scientific doctoral
studies at the University of Oxford, and if accepted by Oxford, the Hepatitis
B Foundation will provide full tuition scholarships for up to two students.
This is an exciting partnership between one of the world’s most
venerable institutions of learning, with nearly 1,000 years of history,
and a young public health organization in the United States. Both organizations
share complementary goals - the University of Oxford is interested in
identifying outstanding students who will work on matters of great importance
and the Hepatitis B Foundation and the IHVR are interested in finding
cures for one of the world’s most confounding, serious diseases.
Fortunately, these are the same types of individuals that the University
of Oxford hopes to attract, too.
The Hepatitis B Foundation training program with the University of Oxford
is only one of two of its kind in the United States (the other program
is at The Scripps Institute, La Jolla, CA). Prof. Raymond Dwek, FRS, an
internationally acclaimed scientist and Head of Biochemistry at the University
of Oxford, and a distinguished member of the scientific advisory board
of the Hepatitis B Foundation, championed the creation of this unique